Protection against lethal Japanese encephalitis virus infection of mice by immunization with the highly attenuated MVA strain of vaccinia virus expressing JEV prM and E genes.
Genes encoding the glycosylated precursor of the membrane (prM) and envelope (E) proteins of a Korean strain of Japanese encephalitis virus (JEV) were inserted into the genome of the host-range restricted, highly attenuated, and safety-tested MVA strain of vaccinia virus. MVA recombinants containing the JEV genes, under strong synthetic or modified H5 vaccinia virus promoters, were isolated. Synthesis of JEV prM and E proteins was detected by immunofluorescence microscopy, flow cytometry, and polyacrylamide gel electrophoresis. Mice inoculated and boosted by various routes with either of the MVA recombinants produced JEV neutralizing antibodies, that had titres comparable with those induced by an inactivated JEV vaccine, as well as haemagglutination-inhibiting antibodies. Mice immunized with 2 x 10(6) infectious units of MVA/JEV recombinants by intramuscular or intraperitoneal routes were completely protected against a 10(5) LD50 JEV challenge at 9 weeks of age.
Nam
J H
JH
Department of Viral Disease, Korean NIH, Seoul, Korea.
Wyatt
L S
LS
Chae
S L
SL
Cho
H W
HW
Park
Y K
YK
Moss
B
B
D000818:Animals; D004672:Encephalitis, Japanese / Q000517:prevention & control*; D015967:Gene Expression Regulation, Viral / Q000502:physiology*; D007114:Immunization; D051379:Mice; D008813:Mice, Inbred ICR; D011995:Recombination, Genetic; D013045:Species Specificity; D014613:Vaccines, Attenuated; D014616:Vaccinia virus / Q000235:genetics / Q000276:immunology*; D014759:Viral Envelope Proteins / Q000235:genetics; D014763:Viral Matrix Proteins / Q000235:genetics; D014765:Viral Vaccines